Natco Pharma informs about press release

14 Jun 2021 Evaluate

Natco Pharma has informed that it has enclosed the Press Release on 14th June 2021 titled ‘NATCO receives approval for Carfilzomib Vials ANDA (generic for KYPROLIS®) in the US market’.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

947.00 -9.55 (-1.00%)
16-Mar-2026 11:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1781.00
Dr. Reddys Lab 1279.90
Cipla 1305.95
Zydus Lifesciences 889.00
Lupin 2277.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×